IP Library Granted Patent US 7,482,113
Granted Patent B2
US 7,482,113 · App. 11/611,914 · Granted Jan 27, 2009

Photothermographic materials containing co-developers with phosphonium cation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,482,113
App. No.
11/611,914
Granted
Jan 27, 2009
Kind
B2
Abstract

Incorporating a combination of a trisphenol reducing agent (developer) and a substituted olefinic co-developer having a phosphonium cation in photothermographic materials improves image tone in resulting images.

Claims (58)

1. A photothermographic material comprising a support having on at least one side thereof, one or more photothermographic imaging layers comprising in reactive association:

a. a photosensitive silver halide,

b. a non-photosensitive source of reducible silver ions,

c. a reducing agent composition for said reducible silver ions comprising a trisphenol reducing agent represented by the following Structure (I),

d. a polymeric binder, and

e. a substituted olefinic co-developer that is represented by the following Structure (IV):

wherein L 1 and L 2 are independently sulfur or a mono-substituted or unsubstituted methylene group,

R 1 and R 2 are independently primary or secondary substituted or unsubstituted alkyl groups having 1 to 12 carbon atoms,

R 3 , R 4 , and R 5 are independently substituted or unsubstituted alkyl groups having 1 to 12 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 12 carbon atoms, or halo groups, and

R 6 , R 7 , R 8 , R 9 , R 10 , and R 11 are independently hydrogen or any substituent that is substitutable on a benzene ring,

wherein V and W are independently aromatic or electron withdrawing groups, provided that at least one of V and W is an electron withdrawing group, or V and W can represent the atoms necessary to form a ring containing an electron withdrawing group,

R is an —O − A + or —S − A + group, and

A + is a quaternary phosphonium cation.

2. The photothermographic material of claim 1 wherein L 1 and L 2 are independently a methylene group or a mono-substituted methylene group, R 1 and R 2 are independently substituted or unsubstituted primary or secondary alkyl groups having 1 to 8 carbon atoms, R 3 , R 4 , and R 5 are independently substituted or unsubstituted alkyl groups having 1 to 6 carbon atoms, and R 6 , R 7 , R 8 , R 9 , R 10 , and R 11 are independently hydrogen, or substituted or unsubstituted methyl, ethyl, or methoxy groups, or chloro groups.

3. The photothermographic material of claim 1 wherein L 1 and L 2 are unsubstituted methylene groups, R 1 and R 2 are the same substituted or unsubstituted primary or secondary alkyl groups, R 3 , R 4 , and R 5 are the same substituted or unsubstituted methyl or ethyl groups, and R 6 , R 7 , R 8 , R 9 , R 10 , and R 11 are independently hydrogen or unsubstituted methyl groups.

4. The photothermographic material of claim 1 wherein said reducing agent of Structure (I) is present in an amount of at least 0.5 mmol/m 2 .

5. The photothermographic material of claim 1 wherein said substituted olefinic co-developer is present at a molar ratio to said reducing agent of Structure (I) of from about 0.001:1 to about 0.02:1.

6. The photothermographic material of claim 1 wherein V is a carboalkoxy group having 2 to 20 carbon atoms, a carboxamido group having 2 to 20 carbon atoms, or a carbocyclic or heterocyclic aryl group having 6 to 10 atoms in the ring, W is a cyano group, and R is an —O − A + group.

7. The photothermographic material of claim 1 wherein said quaternary phosphonium cation A + is represented by either of the following Structures (V) and (VI):

wherein R 25 through R 28 are independently alkyl or aryl groups, and R 29 is an alkylene or arylene group.

8. The photothermographic material of claim 7 wherein R 25 through R 28 are each the same or different phenyl groups, or at least one of R 25 through R 28 is a benzyl group and the rest are the same or different phenyl groups, R 29 is an alkylene group having 1 to 10 carbon atoms in the chain or a 1,2-, 1,3-, or 1,4-substituted phenyl group.

9. The photothermographic material of claim 1 wherein V is a carboalkoxy group having 2 to 9 carbon atoms, a carboxamido group having 2 to 7 carbon atoms, or a halogen-substituted phenyl group, and A + is a tetraphenylphosphonium or benzyltriphenylphosphonium ion.

10. The photothermographic material of claim 1 comprising one or more of the following substituted olefinic co-developers CDP-1, CDP-3, CDP-4, CDP-5, CDP-11, and CDP-12:

11. The photothermographic material of claim 1 wherein the total amount of silver is from about 1 to about 2.6 g/m 2 .

12. The photothermographic material of claim 1 further comprising at least one additional reducing agent that is a monophenol or a bisphenol, or both.

13. The photothermographic material of claim 1 further comprising a protective overcoat layer disposed over said photothermographic layer, and interlayer, carrier layer, or any combination thereof.

14. The photothermographic material of claim 1 that provides a silver black-and-white image.

15. The photothermographic material of claim 1 wherein said photothermographic imaging layer has been coated out of an organic solvent and said polymeric binder is a hydrophobic binder that is soluble in said organic solvent.

16. The photothermographic material of claim 1 wherein said photosensitive silver halide is silver bromide or a silver iodobromide that is present predominantly in cubic or tabular grains,

said non-photosensitive source of reducible silver ions comprises at least silver behenate,

said polymeric binder is a polyvinyl butyral or polyvinyl acetal binder, and

said substituted olefinic co-developer is one or more of CDP-1, CDP-3, CDP-4, CDP-5, CDP-11, and CDP-12 shown below,

said trisphenol reducing agent is Compound I-2 or I-3 as represented by Structure I in which R 1 -R 5 , L 1 , and L 2 are as shown below and is present in an amount of from about 1 to about 5 mmol/m 2 ,

said substituted olefinic co-developer is present in an amount of from about 0.005 to about 0.02 mmol/m 2 , and the molar ratio of said substituted olefinic co-developer to said trisphenol reducing agent is from about 0.001:1 to about 0.02:1, and

the total amount of silver is present in an amount of at least 1 g/m 2 and less than or equal to 2.6 g/m 2 ,

Trisphenol

Reducing

Agent

R 1 , R 2

R 3 , R 5

R 4

L 1 , L 2

I-2

CH 3

CH 3

CH 3

CH 2

I-3

Cyclohexyl

CH 3

CH 3

CH 2 .

17. The photothermographic material of claim 16 further comprising at least one additional reducing agent that is a bisphenol.

18. A method of forming a visible image comprising:

A) imagewise exposing the photothermographic material of claim 1 to electromagnetic radiation to form a latent image, and

B) simultaneously or sequentially, heating said exposed photothermographic material to develop said latent image into a visible image.

19. The method of claim 18 wherein said imagewise exposing is carried out using laser imaging at from about 600 to about 1200 nm or said development is carried out for at least 3 and up to and including 25 seconds, to provide a visible black-and-white image.

20. The method of claim 18 wherein said photothermographic material comprises one or more of the following substituted olefinic co-developers CDP-1, CDP-3, CDP-4, CDP-5, CDP-11, and CDP-12:

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Oct 14, 2022
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL, LLC; QUANTUM MEDICAL IMAGING, L.L.C.; QUANTUM MEDICAL HOLDINGS, LLC; TROPHY DENTAL INC.
Reel/Frame 061681/0380 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (FIRST LIEN) Recorded Oct 14, 2022
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL LLC; QUANTUM MEDICAL IMAGING, L.L.C.; TROPHY DENTAL INC.
Reel/Frame 061683/0441 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (SECOND LIEN) Recorded Oct 14, 2022
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL LLC; QUANTUM MEDICAL IMAGING, L.L.C.; TROPHY DENTAL INC.
Reel/Frame 061683/0601 →
SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 1, 2013
From: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL LLC; QUANTUM MEDICAL IMAGING, L.L.C.; TROPHY DENTAL INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 030724/0154 →
AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT (FIRST LIEN) Recorded Jun 28, 2013
From: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL LLC; QUANTUM MEDICAL IMAGING, L.L.C.; TROPHY DENTAL INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 030711/0648 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (SECOND LIEN) Recorded Mar 13, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.
Reel/Frame 027851/0812 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 12, 2011
From: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL, LLC; QUANTUM MEDICAL IMAGING, L.L.C.; QUANTUM MEDICAL HOLDINGS, LLC; TROPHY DENTAL INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 026269/0411 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2008
From: EASTMAN KODAK COMPANY
To: CARESTREAM HEALTH, INC.
Reel/Frame 020741/0126 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2007
From: SIMPSON, SHARON M.; SAKIZADEH, KUMARS
To: EASTMAN KODAK COMPANY
Reel/Frame 018783/0831 →